
Investors
Long-term value creation in our core spaces for our stakeholders with a distinct purpose of ensuring that every family will have a better tomorrow


Financial Snapshot
75
Years in Operation
USD
159 mn
Market Capitalisation37%
Free Float
USD
311 mn
Total AssetsAAA
Long-term Fitch Rating>5K
EmployeesLatest News
Hemas Delivers Strong Performance in Earnings Growth Performance Review for the Nine Months Ended 31st December 2024
February 06, 2025
Ayati Marks 5 Years of Transforming Lives Over 14,000 Children with Disabilities and Families Empowered
January 29, 2025
Hemas Pharmaceuticals Partners with the 1990 Suwa Seriya Foundation for the ‘Adopt an Ambulance’ Initiative
January 28, 2025